Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Peter Frederick Juby is active.

Publication


Featured researches published by Peter Frederick Juby.


Annual Reports in Medicinal Chemistry | 1971

Chapter 18. Non-steroidal Antiinflammatory Agents

Peter Frederick Juby; Thomas William Hudyma

Publisher Summary This chapter highlights the research in the area of nonsteroidal antiinflammatory agents (NAA) with an emphasis on work relating to the chronic arthritic diseases. There have been few notable developments in the past in in vivo methods used to screen for and evaluate NAA. Increasing reliance is being placed upon the adjuvant-induced arthritis assay in the rat because it is felt that the histochemistry and pathology of this autoimmune disease most closely resemble the histochemistry and pathology of some of the human arthritic diseases. An improved quantitative method that employs the dog has been reported in which the pressure exerted by the dog paw is measured after injection of an inflammatory agent into the corresponding knee joint. In another study, intrazole (BL-R743), aspirin, and phenylbutazone effectively inhibited rabbit platelet aggregation in both in vitro and in vivo screens. Aspirin and other NAA inhibited human blood platelet aggregation. In all these cases, the compounds were considered to work by inhibiting the release mechanism.


Journal of Medicinal Chemistry | 1972

Antiinflammatory activity of some indan-1-carboxylic acids and related compounds

Peter Frederick Juby; W. R. Goodwin; Thomas W. Hudyma; Richard Anthony Partyka


Journal of Medicinal Chemistry | 1988

Substituted benzamides. 1. Potential nondopaminergic antagonists of chemotherapy-induced nausea and emesis.

Ivo Monkovic; David Willner; Michael A. Adam; Myron Brown; Ronnie R. Crenshaw; Carl E. Fuller; Peter Frederick Juby; George M. Luke; John A. Matiskella; Thomas A. Montzka


Journal of Medicinal Chemistry | 1982

Antiallergy agents. 2. 2-Phenyl-5-(1H-tetrazol-5-yl)pyrimidin-4(3H)-ones.

Peter Frederick Juby; Thomas William Hudyma; Myron Brown; John M. Essery; Richard Anthony Partyka


Journal of Medicinal Chemistry | 1979

Antiallergy agents. 1. 1,6-Dihydro-6-oxo-2-phenylpyrimidine-5-carboxylic acids and esters.

Peter Frederick Juby; Thomas William Hudyma; Myron Brown; John M. Essery; Richard Anthony Partyka


Journal of Medicinal Chemistry | 1972

Antiinflammatory activity and structure-activity relationships of some 1,2,3,4-tetrahydro-1-naphthoic acids and related compounds.

Peter Frederick Juby; W. R. Goodwin; Thomas W. Hudyma; Richard Anthony Partyka


Archive | 1984

Use of substituted 3- (1H-tetrazol-5-yl) -4H-pyrido (1,2-a) -pyrimidin-4-one compounds as cytoprotective agents

Peter Frederick Juby; Thomas William Hudyma; Douglas G Colton


Archive | 1984

Verwendung substituierter 3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)-pyrimidin-4-on-verbindungen als cytoprotective wirkstoffe Use of substituted 3- (1H-tetrazol-5-yl) -4H-pyrido (1,2-a) pyrimidin-4-one compounds as cytoprotective agents

Peter Frederick Juby; Thomas William Hudyma; Douglas G Colton


Archive | 1978

Foerfarande Foer framstaellning of nya terapeutiskt anvaendbara 4-oxo-4H-pyrimido (2,1-a) isoquinolin-3-karboxylsyraderivat

Peter Frederick Juby; Thomas William Hudyma; Richard Anthony Partyka


Archive | 1978

Analogifremgangsmaade for the preparation of 4-oxo-4H-pyrimido-oe2,1-aaaisoquinoliner

Peter Frederick Juby; Thomas William Hudyma; Richard Anthony Partyka

Collaboration


Dive into the Peter Frederick Juby's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge